We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
Cap. Flow
+$2.44B
Cap. Flow %
5.94%
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$170M
2
TSLA icon
Tesla
TSLA
+$155M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
TSM icon
TSMC
TSM
+$87.6M
5
NTR icon
Nutrien
NTR
+$86.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$150M
2
NOC icon
Northrop Grumman
NOC
+$112M
3
HON icon
Honeywell
HON
+$98.1M
4
LIN icon
Linde
LIN
+$87M
5
UBER icon
Uber
UBER
+$72.9M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 16.16%
3 Financials 10.71%
4 Consumer Discretionary 9.79%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLUE
1426
DELISTED
bluebird bio
BLUE
-2,064
Closed -$513K
BNR
1427
Burning Rock Biotech
BNR
$114M
-265
Closed -$428K
BZUN
1428
Baozun
BZUN
$169M
-5,194
Closed -$92K
CGAU
1429
Centerra Gold
CGAU
$4.21B
-21,800
Closed -$145K
CGEN icon
1430
Compugen
CGEN
$231M
-30,000
Closed -$177K
CHPT icon
1431
ChargePoint
CHPT
$161M
-17,100
Closed -$6.99M
CLB icon
1432
Core Laboratories
CLB
$574M
-59,000
Closed -$1.61M
CLLS
1433
Cellectis
CLLS
$290M
-7,000
Closed -$86K
COLL icon
1434
Collegium Pharmaceutical
COLL
$874M
-10,400
Closed -$204K
DOX icon
1435
Amdocs
DOX
$6.22B
-29,715
Closed -$2.23M
ESPR
1436
DELISTED
Esperion Therapeutics
ESPR
-10,000
Closed -$123K
EVGO icon
1437
EVgo
EVGO
$500M
-285,000
Closed -$2.39M
GERN icon
1438
Geron
GERN
$988M
-100,000
Closed -$138K
GLOB icon
1439
Globant
GLOB
$1.69B
-1,500
Closed -$424K
LKFT
1440
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
-2,760
Closed -$137K
GOTU icon
1441
Gaotu Techedu
GOTU
$441M
-7,523
Closed -$20K
HBI
1442
DELISTED
Hanesbrands
HBI
-1,159
Closed -$21K
INVA icon
1443
Innoviva
INVA
$1.5B
-37,200
Closed -$634K
INZY
1444
DELISTED
Inozyme Pharma
INZY
-7,000
Closed -$78K
KALA icon
1445
KALA BIO
KALA
$14.5M
-8
Closed -$55K
KB icon
1446
KB Financial Group
KB
$41.7B
-18,186
Closed -$843K
KNSA icon
1447
Kiniksa Pharmaceuticals
KNSA
$6.04B
-10,000
Closed -$114K
KPTI icon
1448
Karyopharm Therapeutics
KPTI
$44.6M
-2,413
Closed -$211K
KTB icon
1449
Kontoor Brands
KTB
$4.23B
$0 ﹤0.01%
1
LEG icon
1450
Leggett & Platt
LEG
$1.33B
-441
Closed -$21K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review

As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $150M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
  • DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
  • DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
  • DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.